Discontinuation of Direct Oral Anticoagulants in Response to Attorney Advertisements: Data From the FDA Adverse Event Reporting System
Ann Pharmacother
.
2019 Sep;53(9):962-963.
doi: 10.1177/1060028019849664.
Epub 2019 May 5.
Authors
Mohamed Mohamoud
,
Saharat Patanavanich
,
Page Crew
,
Lynda McCulley
,
Monica Munoz
,
Cindy Kortepeter
,
S Christopher Jones
,
Daniel Woronow
,
Gerald Dal Pan
PMID:
31055957
PMCID:
PMC8919214
DOI:
10.1177/1060028019849664
No abstract available
Publication types
Letter
Grants and funding
FD999999/ImFDA/Intramural FDA HHS/United States